一个个性化的多任务框架,用于实时预测1型糖尿病患者的血糖水平
Huazhong Yang1, Wang Li2, Maojin Tian3
1School of Computer Science, Yangtze University, Jingzhou 434000, China.
Mathematical biosciences and engineering : MBE
|March 8, 2024
概括
这项研究开发了一个个性化的AI模型,用于预测1型糖尿病管理的血糖水平. 该模型显示高精度,有助于临床决策和改善患者的结果.
科学领域:
- 生物医学工程 生物医学工程
- 医疗保健中的人工智能
- 糖尿病 技术 技术
背景情况:
- 血糖水平 (BGL) 的实时预测对于1型糖尿病 (T1D) 的管理至关重要,但仍然具有挑战性.
- 现有的方法往往缺乏个性化,并与动态BGL波动作斗争.
研究的目的:
- 开发和评估一个个性化的多任务框架,以准确预测T1D患者的血糖水平.
- 通过优化一个修改后的GRU网络与TCN和注意力机制来提高预测准确性.
主要方法:
- 使用患者数据 (性别,年龄) 作为修改后的GRU网络的输入,创建了一个个性化的多任务框架.
- 通过衰变因子,TCN网络和注意力机制来优化超参数,以改善特征提取.
- 俄俄州T1DM临床数据集用于培训和评估,使用RMSE,MAE和克拉克错误网格分析 (EGA).
主要成果:
- 该模型在30分钟的预测时间内实现了平均RMSE16.896 mg/dL和MAE9.978 mg/dL.
- 对于60分钟的预测时间,该模型的平均RMSE为28.881 mg/dL,MAE为19.347 mg/dL.
- EGA的分析证实了高准确度,预测在30分钟和60分钟的时间范围内都处于临床上可接受的A和B区域内.
结论:
- 拟议的个性化多任务预测模型在T1D患者预测BGL方面表现出卓越的准确性和临床可行性.
- 这一框架为临床决策支持提供了巨大的潜力,有助于改善糖尿病管理和患者的治疗结果.
- 在GRU模型中整合TCN和注意力机制,提高了对动态生理数据的预测能力.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Hypoglycemia and Glucagon
260
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
260
Diabetes: Management and Pharmacotherapy
282
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
282
Insulin: Dosing Regimen and Adverse Effects
170
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
170
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K


